Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Teva
Healthtrust
UBS
Harvard Business School
Chinese Patent Office
Covington
Mallinckrodt
Cipla

Generated: May 27, 2018

DrugPatentWatch Database Preview

PROBENECID W/ COLCHICINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Probenecid W/ Colchicine, and what generic alternatives are available?

Probenecid W/ Colchicine is a drug marketed by Lederle and Watson Labs and is included in two NDAs.

The generic ingredient in PROBENECID W/ COLCHICINE is colchicine; probenecid. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
Summary for PROBENECID W/ COLCHICINE
Drug patent expirations by year for PROBENECID W/ COLCHICINE

US Patents and Regulatory Information for PROBENECID W/ COLCHICINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle PROBENECID W/ COLCHICINE colchicine; probenecid TABLET;ORAL 086954-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs PROBENECID W/ COLCHICINE colchicine; probenecid TABLET;ORAL 083221-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fuji
Chinese Patent Office
Queensland Health
Merck
Citi
Boehringer Ingelheim
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.